Thromb Haemost 1979; 42(03): 1018-1021
DOI: 10.1055/s-0038-1656992
Original Article
Schattauer GmbH Stuttgart

Thrombus Weight as a Measure of Hypercoagulability Induced by Drugs

Maura MacIomhair
The Department of Experimental Medicine, University College, Galway, Ireland
,
S M Lavelle
The Department of Experimental Medicine, University College, Galway, Ireland
› Author Affiliations
Further Information

Publication History

Received 27 February 1979

Accepted 25 March 1979

Publication Date:
23 August 2018 (online)

Summary

Thrombus weight was used as a measure of the thrombus enhancing effect of drugs in 135 rats. The weight of thrombus formed in one hour, on a 20 × 0.5 mm platinum wire, inserted in the vena cava was taken as a measure of thrombosis. The change in thrombus weight which followed the injection of ellagic acid to activate the coagulation system, adenosine diphosphate to activate the platelets, and epsilon-aminocaproic acid to inhibit the fibrinolytic system, was measured. Pilot studies showed that the drug doses used brought about the appropriate changes in the factors named. The mean thrombus weight in 45 control animals was 1.93 mg. Ellagic acid increased it about five-fold, and epsilon- aminocaproic acid almost two-fold, while adenosine diphosphate reduced it by almost a half. Concurrent controls were used in each case. Clotting tests (whole blood clotting time, kaolin-activated whole blood clotting time, thrombin time, and partial thromboplastin time), performed at the end of the hour, showed no significant correlation with thrombus weight.

 
  • References

  • 1 Bell WN, Alton HG. 1954; A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature (London) 174: 880
  • 2 Bom RE, Ratnoff OD. 1964; Studies on the pathogenesis of thrombosis: an experimental “hypercoagulable state” induced by the intravenous injection of ellagic acid. Journal of Laboratory and Clinical Medicine 64: 385
  • 3 Brecher G, Cronkite EP. 1950; Morphology and enumeration of human blood platelets. Journal of Applied Physiology 3: 356
  • 4 Dejana E, De Gaetano G, Bonaccorsi A. 1977; Role of the lung in the development of cardiovascular modifications during ADP infusion in the rat. Thrombosis Research 12: 47
  • 5 Gallimore MJ, Tyler HM, Shaw JT B. 1971; The measurement of fibrinolysis in the rat. Thrombosis et diathesis haemorrhagica 26: 295
  • 6 Lavelle SM, Maciomhair M. 1975. The antithrombotic effects of warafin, dipyridamole and aspirin in the rat. In Drouet, Goudet. (Ed) Abstracts Vth Congress of the International Society on Thrombosis and Haemostasis. Paris: 21.07.1975. p 104
  • 7 Mason RG, Wolf RH, Zucker WH, Shinoda BA. 1976; Dynamics of thrombus formation on an artificial surface in vivo. American Journal of Pathology 82: 445
  • 8 Olsen PS, Ljungquist U, Bergentz SE. 1973; Thrombus formation in stainless steel tubes used as vascular implants in the dog. Thrombosis Research 4: 271
  • 9 Sise HS, Moschos CB, Becker R. 1962; On the nature of hypercoagulability. American Journal of Medicine 33: 667